Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway

OBJECTIVES: To investigate the efficacy and potential molecular mechanism of Huangkui capsule in combination with leflunomide (HKL) for the treatment of immunoglobulin A nephropathy (IgAN) METHODS: IgAN rat models were constructed by treating rats with bovine serum albumin, lipopolysaccharide, and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Shuwen, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614623/
https://www.ncbi.nlm.nih.gov/pubmed/34909911
http://dx.doi.org/10.6061/clinics/2021/e2904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614623/
https://www.ncbi.nlm.nih.gov/pubmed/34909911
http://dx.doi.org/10.6061/clinics/2021/e2904

Ejemplares similares